Showing results (21-30 of 73) with videos related to
Sort By:
Pageof 8
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 27, 2017
Validity and Reliability of Value Assessment Frameworks for New Cancer DrugsTanya G K Bentley, Joshua T Cohen, Elena B Elkin, et al.Journal of Managed Care & Specialty Pharmacy|May 24, 2017
Measuring the Value of New Drugs: Validity and Reliability of 4 Value Assessment Frameworks in the Oncology SettingTanya G K Bentley, Joshua T Cohen, Elena B Elkin, et al.Transplantation and Cellular Therapy|June 13, 2024
Clonal Hematopoiesis is Associated With Severe Cytokine Release Syndrome in Patients Treated With Chimeric Antigen Receptor T-Cell (CART) TherapyScott R Goldsmith, Geoffrey Shouse, F Lennie Wong, et al.Cancers|March 29, 2023
Long-Term Follow-Up of Bridging Therapies Prior to CAR T-Cell Therapy for Relapsed/Refractory Large B Cell LymphomaColton Ladbury, Savita Dandapani, Claire Hao, et al.Clinical Lymphoma, Myeloma & Leukemia|June 10, 2023
Results of a Phase II Trial of Allogeneic Hematopoietic Stem Cell Transplantation Using <sup>90</sup>Y-Ibritumomab Tiuxetan (Zevalin) in Combination With Fludarabine and Melphalan in Patients With High-Risk B-Cell Non-Hodgkin's LymphomaMatthew Mei, Joycelynne Palmer, Nicole Ni-Chun Tsai, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 17, 2020
Long-Term Outcomes of Allogeneic Hematopoietic Cell Transplant with Fludarabine and Melphalan Conditioning and Tacrolimus/Sirolimus as Graft-versus-Host Disease Prophylaxis in Patients with Acute Lymphoblastic LeukemiaMatthew Mei, Ni-Chun Tsai, Sally Mokhtari, et al.Cancer|February 15, 2024
Coronary artery calcium and cardiovascular outcomes in patients with lymphoma undergoing autologous hematopoietic cell transplantationStephanie Wu, June-Wha Rhee, Aleksi Iukuridze, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 1, 2020
Outcome of Allogeneic Hematopoietic Cell Transplantation after Venetoclax and Hypomethylating Agent Therapy for Acute Myelogenous LeukemiaKaramjeet S Sandhu, Sanjeet Dadwal, Dongyun Yang, et al.Blood|December 12, 2018
Regulation of SOX11 expression through CCND1 and STAT3 in mantle cell lymphomaAtish Mohanty, Natalie Sandoval, An Phan, et al.Clinical Lymphoma, Myeloma & Leukemia|January 12, 2021
Polatuzumab Vedotin for Relapsed/Refractory Aggressive B-cell Lymphoma: A Multicenter Post-marketing AnalysisStephen D Smith, Paolo Lopedote, Yazeed Samara, et al.Pageof 8